Viewing Study NCT07226557

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:35 PM
Ignite Modification Date: 2026-01-28 @ 8:15 AM
Study NCT ID: NCT07226557
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-10
First Post: 2025-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation
Sponsor: National Institutes of Health Clinical Center (CC)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carbapenem Resistant Bacterial Infection View
None Acinetobacter Baumannii Infection View
None Antimicrobial Drug Resistance View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Carbapenem-resistant Acinetobacter baumannii View
None Cefiderocol View
None Target trial emulation View